Japanese
Title家兎VX-2癌における99mTc-Tetrofosminと99mTc-MIBIの腫瘍集積性に関する比較検討
Subtitle短報
Authors大塚信昭*, 玉田勉*, 三村浩朗*, 曽根照喜*, 森田浩一*, 友光達志*, 柳元真一*, 福永仁夫*
Authors(kana)
Organization*川崎医科大学核医学
Journal核医学
Volume34
Number10
Page939-943
Year/Month1997/10
Article報告
Publisher日本核医学会
Abstract要旨 最近, 心筋血流イメージ剤が腫瘍シンチグラフィに応用されている. これらのうち99mTc-tetrofosmin (99mTc-TF) と99mTc-MIBIについて家兎VX-2癌を用いて腫瘍集積性について比較検討を行った. VX-2癌を大腿部に移植後, 17〜21日目の担癌家兎7羽について腫瘍集積を初期像 (5分後) と後期像 (50分後) における軟部組織に対する腫瘍集積比にて算出した. 99mTc-TFと99mTc-MIBIの初期腫瘍集積性は同様に高いものの, 99mTc-TFは99mTc-MIBIに比してwashoutが早いことが示され, 腫瘍集積に対する両薬剤の違いが示唆された. 「I. はじめに」心筋血流シンチグラフィ製剤として開発された99mTc-hexakis-2-methoxy isobutyl-isonitrile (99mTc-MIBI) と, 99mTc-tetrofosmin (99mTc-TF) は各種腫瘍への集積が確認され, 腫瘍親和性放射性医薬品として注目されている.
Practice臨床医学:一般
KeywordsTumor scintigraphy, 99mTc-tetrofosmin, 99mTc-MIBI, VX-2 cancer.
English
TitleComparative Study on the Tumor Accumulation of 99mTc-Tetrofosmin and 99mTc-MIBI in Rabbits Bearing VX-2 Cancer
SubtitleShort Communication
AuthorsNobuaki OTSUKA, Tsutomu TAMADA, Hiroaki MIMURA, Teruki SONE, Koichi MORITA, Tatsushi TOMOMITSU, Shinichi YANAGIMOTO, Masao FUKUNAGA
Authors(kana)
OrganizationDepartment of Nuclear Medicine, Kawasaki Medical School
JournalThe Japanese Journal of nuclear medicine
Volume34
Number10
Page939-943
Year/Month1997/10
ArticleReport
PublisherTHE JAPANESE SOCIETY OF NUCLEAR MEDICINE
AbstractEach of myocardial blood flow imaging agents has a potential usefulness as an agent for tumor scintigraphy. The tumor accumulation and washout of 99mTc-tetrofosmin and 99mTc-MIBI were comparatively studied using rabbits bearing VX-2 cancer. From seventeen to twenty days after the implantation of VX-2 cancer into the femoral region of seven rabbits, tumor to soft tissue accumulation ratio (T/S ratio) of each agent was calculated in early images (5 min after injection) and in late images (50 min after injection). Compared with 99mTc-tetrofosmin, the T/S ratio of 99mTc-MIBI was higher and, moreover, the washout was delayed. These results suggest that there is a difference in tumor accumulation property between these two agents.
PracticeClinical medicine
KeywordsTumor scintigraphy, 99mTc-tetrofosmin, 99mTc-MIBI, VX-2 cancer.

【全文PDF】